Springowl Associates’s NEOPHOTONICS CORP NPTN Stock Holding History

Springowl Associates’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-59,499	Closed	-$525K	–	31
2019 Q4	$525K	Sell	59,499 -140,000	-70%	-$1.05M	0.54%	23
2019 Q3	$1.22M	Sell	199,499 -50,000	-20%	-$281K	1.58%	13
2019 Q2	$1.04M	Buy	249,499 +15,000	+6%	+$79.1K	1.41%	15
2019 Q1	$1.48M	Buy	234,499 +47,500	+25%	+$333K	1.98%	8
2018 Q4	$1.21M	Buy	186,999 +72,000	+63%	+$551K	1.72%	11
2018 Q3	$954K	Sell	114,999 -20,001	-15%	-$152K	0.77%	21
2018 Q2	$841K	Buy	+135,000	New	+$858K	0.59%	20

Other funds holding NPTN

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Springowl Associates's NPTN Position: Q1 2020 in Review

Springowl Associates sold out of NEOPHOTONICS CORP (NPTN) in Q1 2020, closing a stake of 59,499 shares — an estimated $525K sold.

Springowl Associates first reported a position in NPTN in Q2 2018 and held it in 7 quarters. The position peaked at $1.48M in Q1 2019. 135 funds tracked by Wall St. Rank hold NPTN as of Q1 2020.

Springowl Associates reported no remaining NEOPHOTONICS CORP position as of Q1 2020 after selling out during the quarter.
Springowl Associates sold 59,499 NEOPHOTONICS CORP shares in Q1 2020, an estimated $525K.
Springowl Associates first reported a position in NEOPHOTONICS CORP in Q2 2018 and held it in 7 quarters.
Springowl Associates's NEOPHOTONICS CORP position peaked at $1.48M in Q1 2019.
135 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2020.

Based on Springowl Associates's 13F filing for Q1 2020, filed 15 May 2020.